Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12
暂无分享,去创建一个
J. Leonard | S. Goldman | K. Waldburger | Kristine E. Waldburger | Samuel J. Goldman | K. Waldburger
[1] V. Kuchroo,et al. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. , 1993, Journal of immunology.
[2] Susanne A. Fischer,et al. Interleukin‐12/T cell stimulating factor, a cytokine with multiple effects on T helper type 1 (Th1) but not on Th2 cells , 1993, European journal of immunology.
[3] R. Schaub,et al. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response , 1993, The Journal of experimental medicine.
[4] R. Rerko,et al. Recombinant interleukin 12 cures mice infected with Leishmania major , 1993, The Journal of experimental medicine.
[5] G. Trinchieri,et al. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells , 1993, The Journal of experimental medicine.
[6] C. Janeway,et al. Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma , 1993, The Journal of experimental medicine.
[7] K. Mohler,et al. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. , 1992, Journal of immunology.
[8] W. Paul,et al. The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice , 1992, The Journal of experimental medicine.
[9] F. Sánchez‐Madrid,et al. Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrin , 1992, Nature.
[10] F. Finkelman,et al. Effect of anti-interferon-γ and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse , 1992, Journal of Neuroimmunology.
[11] J. Merrill,et al. Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[12] T. Mosmann,et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. , 1991, Journal of immunology.
[13] R. Hewick,et al. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. , 1991, Journal of immunology.
[14] E. Butcher,et al. Expression of vascular addressins and ICAM-1 by endothelial cells in the spinal cord during chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB/H mouse. , 1991, Immunology.
[15] G. Trinchieri,et al. Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers , 1991, The Journal of experimental medicine.
[16] A. Weinberg,et al. IL-4 directs the development of Th2-like helper effectors. , 1990, Journal of immunology.
[17] R. Sobel,et al. Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. , 1989, Journal of immunology.
[18] C. Pettinelli,et al. Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+ 2- T lymphocytes. , 1981, Journal of immunology.
[19] A. Cross,et al. Homing to central nervous system vasculature by antigen-specific lymphocytes. II. Lymphocyte/endothelial cell adhesion during the initial stages of autoimmune demyelination. , 1990, Laboratory investigation; a journal of technical methods and pathology.